BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 36142410)

  • 1. Molecular Mechanisms of Drug Resistance and Epidemiology of Multidrug-Resistant Variants of
    Mlynarczyk-Bonikowska B; Kowalewski C; Krolak-Ulinska A; Marusza W
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.
    Jiang FX; Lan Q; Le WJ; Su XH
    BMC Infect Dis; 2017 May; 17(1):366. PubMed ID: 28545411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
    Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
    J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014-2016: focus on extended-spectrum cephalosporins and azithromycin.
    Ryan L; Golparian D; Fennelly N; Rose L; Walsh P; Lawlor B; Mac Aogáin M; Unemo M; Crowley B
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1661-1672. PubMed ID: 29882175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissemination and genome analysis of high-level ceftriaxone-resistant
    Lin X; Chen W; Xie Q; Yu Y; Liao Y; Feng Z; Qin X; Wu X; Tang S; Zheng H
    Emerg Microbes Infect; 2022 Dec; 11(1):344-350. PubMed ID: 34994305
    [No Abstract]   [Full Text] [Related]  

  • 6. Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study.
    Sánchez-Busó L; Cole MJ; Spiteri G; Day M; Jacobsson S; Golparian D; Sajedi N; Yeats CA; Abudahab K; Underwood A; Bluemel B; Aanensen DM; Unemo M;
    Lancet Microbe; 2022 Jun; 3(6):e452-e463. PubMed ID: 35659907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.
    Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M
    J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance, a Novel Antimicrobial Resistance Multilocus Typing Scheme for Tracking Global Dissemination of N. gonorrhoeae Strains.
    Demczuk W; Sidhu S; Unemo M; Whiley DM; Allen VG; Dillon JR; Cole M; Seah C; Trembizki E; Trees DL; Kersh EN; Abrams AJ; de Vries HJC; van Dam AP; Medina I; Bharat A; Mulvey MR; Van Domselaar G; Martin I
    J Clin Microbiol; 2017 May; 55(5):1454-1468. PubMed ID: 28228492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype.
    Tanaka M; Nakayama H; Huruya K; Konomi I; Irie S; Kanayama A; Saika T; Kobayashi I
    Int J Antimicrob Agents; 2006 Jan; 27(1):20-6. PubMed ID: 16318912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.
    Shimuta K; Unemo M; Nakayama S; Morita-Ishihara T; Dorin M; Kawahata T; Ohnishi M;
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5225-32. PubMed ID: 23939890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea.
    Lee H; Unemo M; Kim HJ; Seo Y; Lee K; Chong Y
    J Antimicrob Chemother; 2015 Sep; 70(9):2536-42. PubMed ID: 26084303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.
    Thakur SD; Starnino S; Horsman GB; Levett PN; Dillon JR
    J Antimicrob Chemother; 2014 Jun; 69(6):1510-6. PubMed ID: 24532681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance and molecular characteristics of Neisseria gonorrhoeae isolates from men who have sex with men.
    Calado J; Castro R; Lopes Â; Campos MJ; Rocha M; Pereira F
    Int J Infect Dis; 2019 Feb; 79():116-122. PubMed ID: 30412735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.
    Cámara J; Serra J; Ayats J; Bastida T; Carnicer-Pont D; Andreu A; Ardanuy C
    J Antimicrob Chemother; 2012 Aug; 67(8):1858-60. PubMed ID: 22566592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand.
    Nokchan N; Wongsurawat T; Jenjaroenpun P; Nitayanon P; Tribuddharat C
    PLoS One; 2022; 17(7):e0271657. PubMed ID: 35905043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.
    Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P;
    Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Epidemiology of Gonococcal Resistance to Extended-Spectrum Cephalosporins, Macrolides, and Fluoroquinolones in the United States, 2000-2013.
    Grad YH; Harris SR; Kirkcaldy RD; Green AG; Marks DS; Bentley SD; Trees D; Lipsitch M
    J Infect Dis; 2016 Nov; 214(10):1579-1587. PubMed ID: 27638945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.
    Unemo M; Golparian D; Nicholas R; Ohnishi M; Gallay A; Sednaoui P
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1273-80. PubMed ID: 22155830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.
    Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA
    BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.
    Endimiani A; Guilarte YN; Tinguely R; Hirzberger L; Selvini S; Lupo A; Hauser C; Furrer H
    BMC Infect Dis; 2014 Feb; 14():106. PubMed ID: 24568221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.